Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension.

Jung-Ick ByunDo-Yong KimJangsup MoonHye-Rim ShinJun-Sang SunwooWoo-Jin LeeHan-Sang LeeKyung-Il ParkSoon Tae Lee Keun Hwa JungKi-Young JungManho KimSang Kun Lee Kon Chu

Published in: Annals of clinical and translational neurology (2019)

One-month atomoxetine treatment was effective and safe in nOH patients. Atomoxetine improved orthostatic BP changes as much as midodrine and was better in terms of ameliorating nOH symptoms.

Keyphrases

attention deficit hyperactivity disorder
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
spinal cord injury
peritoneal dialysis
autism spectrum disorder
depressive symptoms
patient reported